echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Amino Acids Research > The direction of the recombination of the plum creature "dramatic"

    The direction of the recombination of the plum creature "dramatic"

    • Last Update: 2020-06-29
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Meihua Bio announced today the direction of restructuring, the company intends to acquire amino acid fermentation assets and their supporting assets, and the counterparty is a South Korean listed company named Hi-JieJYH
    Plum Bio today announced that the company received notice from controlling shareholder Meng Qingshan, Meng Qingshan and the counterparty Xijie First Sugar Co., Ltd("Hi-Jie") signed some of the terms of the restructuring framework agreement is not legally bindingThe framework agreement shows that the reorganization is divided into two steps, first set to increase the issuance, and then the transfer of old shares, the two are advanced to each otherIn terms of fixed issuance, Meihua Bio intends to issue shares to Hi-Jie to purchase its amino acid fermentation assets and supporting assets in China, and in respect of the transfer of old shares, Meng Qingshan and Meihua Bio-related shareholders intend to transfer part of Meihua Bio shares to Hi-Jie or other parties designated by himJYH
    According to the announcement, Hijie is a south Korean exchange-listed joint-stock company, which started with the sugar industry, the business area gradually expanded to seasonings, cooking oil, meat processing, frozen food, life sciences and household goodsJYH
     (Reporting by Wang Weiye and Editing by Sun Yu)JYHMeihua Bio announced today the direction of restructuring of the "dramatic" company to acquire amino acid fermentation assets and their ancillary assets, while the counterparty is a South Korean listed company called Hi-JieJYH
    Plum Bio today announced that the company received notice from controlling shareholder Meng Qingshan, Meng Qingshan and the counterparty Xijie First Sugar Co., Ltd ("Hi-Jie") signed some of the terms of the restructuring framework agreement is not legally binding The framework agreement shows that the reorganization is divided into two steps, first set to increase the issuance, and then the transfer of old shares, the two are advanced to each other In terms of fixed issuance, Meihua Bio intends to issue shares to Hi-Jie to purchase its amino acid fermentation assets and supporting assets in China, and in respect of the transfer of old shares, Meng Qingshan and Meihua Bio-related shareholders intend to transfer part of Meihua Bio shares to Hi-Jie or other parties designated by him JYH
      According to the announcement, Hijie is a south Korean exchange-listed joint-stock company, which started with the sugar industry, the business area gradually expanded to seasonings, cooking oil, meat processing, frozen food, life sciences and household goods JYH
     (Reporting by Wang Weiye and Editing by Sun Yu) JYH shared a feed on Weibo
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.